fisetin senolytic
Selected indexed studies
- Senolytic drugs: from discovery to translation. (J Intern Med, 2020) [PMID:32686219]
- Fisetin is a senotherapeutic that extends health and lifespan. (EBioMedicine, 2018) [PMID:30279143]
- Fisetin as a senotherapeutic agent: Evidence and perspectives for age-related diseases. (Mech Ageing Dev, 2024) [PMID:39384074]
_Worker-drafted node — pending editorial review._
Connections
fisetin senolytic helps
fisetin senolytic protects against
Sources
- Fisetin as a senotherapeutic agent: Evidence and perspectives for age-related diseases. (2024) pubmed
- Fisetin is a senotherapeutic that extends health and lifespan. (2018) pubmed
- Intermittent supplementation with fisetin improves arterial function in old mice by decreasing cellular senescence. (2024) pubmed
- Senolytic drugs: from discovery to translation. (2020) pubmed
- Senolytic treatment with fisetin reverses age-related endothelial dysfunction partially mediated by SASP factor CXCL12. (2025) pubmed
- Cellular Senescence: A Translational Perspective. (2017) pubmed
- Endothelial senescent-cell-specific clearance alleviates metabolic dysfunction in obese mice. (2025) pubmed
- Intermittent Supplementation With Fisetin Improves Physical Function and Decreases Cellular Senescence in Skeletal Muscle With Aging: A Comparison to Genetic Clearance of Senescent Cells and Synthetic Senolytic Approaches. (2025) pubmed
- The Senolytic Drug Fisetin Attenuates Bone Degeneration in the Zmpste24 (-/-) Progeria Mouse Model. (2023) pubmed
- IL-23R is a senescence-linked circulating and tissue biomarker of aging. (2025) pubmed